Investor Relations Corporate Profile Evolus is a medical aesthetics company focused on providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures. FINANCIAL NEWS September 5, 2018 Evolus Appoints Ashwin K. Agarwal as Vice President, Finance, Investor Relations and Treasury August 29, 2018 Evolus Receives Acceptance of FDA BLA Resubmission for DWP-450 August 17, 2018 Evolus Granted Approval of DWP-450 by Health Canada View all EVENTS Q2 2018 Evolus Earnings Conference Call Aug 2, 2018 at 8:30 AM EDT JMP Securities Life Sciences Conference Jun 20, 2018 at 9:00 AM EDT Cantor 2018 Dermatology & Aesthetics Summit Jun 19, 2018 at 12:00 PM EDT View all PRESENTATION June 2018 Investor Presentation
September 5, 2018 Evolus Appoints Ashwin K. Agarwal as Vice President, Finance, Investor Relations and Treasury
